The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Dry eye disease (DED), keratoconjunctivitis sicca or dysfunctional tear syndrome, is the most
prevalent ophthalmic disease which affects a substantial segment of people worldwide with …

Dry eye disease (DED) is one of the most common ocular surface disorders characterised by
a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature …

Several aspects of the quality of life (QoL) and treatment satisfaction of patients with dry eye
disease (DED) may be underestimated. Ocular symptoms, which are assessed by validated …

Purpose To assess the six-month therapeutic profiles of lipid and non-lipid-based artificial
tear supplements in managing dry eye disease (DED). Methods Ninety-nine participants …

At present, more and more diseases are associated with the lubrication dysfunction, which
requires a systematic study of the complex lubrication behavior of tissues and organs in …

The development of novel therapies for Dry Eye Disease (DED) is formidable, and relatively
few treatments evaluated have been approved for marketing. In this report, the …

This study reviewed the efficacy and safety of intense pulsed light (IPL) for the treatment of
dry eye disease (DED). The PubMed database was used to conduct the literature search …

Aim The prevalence of contact lens related dry eye (CLDE) is high and can lead to ocular
discomfort, reduced quality of vision and life. The aim of this study was to assess the efficacy …

Purpose To assess dry eye treatment with four preservative-free dry eye artificial tear
treatments to facilitate evidence-based prescribing. Methods A randomised, single masked …